Hye In Lim

439 total citations
17 papers, 371 citations indexed

About

Hye In Lim is a scholar working on Surgery, Cancer Research and Biotechnology. According to data from OpenAlex, Hye In Lim has authored 17 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 6 papers in Cancer Research and 5 papers in Biotechnology. Recurrent topics in Hye In Lim's work include Cancer Research and Treatments (5 papers), Breast Cancer Treatment Studies (4 papers) and Nanoplatforms for cancer theranostics (4 papers). Hye In Lim is often cited by papers focused on Cancer Research and Treatments (5 papers), Breast Cancer Treatment Studies (4 papers) and Nanoplatforms for cancer theranostics (4 papers). Hye In Lim collaborates with scholars based in South Korea, United States and Japan. Hye In Lim's co-authors include Seok Jin Nam, Wan Wook Kim, Jeong Eon Lee, Jae Hyuck Choi, Jee Soo Kim, Jung‐Han Kim, Jun‐Ho Choe, Se-Kyung Lee, Jung‐Hyun Yang and Sangmin Kim and has published in prestigious journals such as Breast Cancer Research and Treatment, Cellular Signalling and Phytomedicine.

In The Last Decade

Hye In Lim

16 papers receiving 359 citations

Peers

Hye In Lim

ONCOL

SURGE

RNMI

Mounes Aliyari Ghasebeh United States

Changyuan Wei China

Andreas Wirger Germany

H.G. Beger Germany

Ryan Morrison United States

Jianzhuang Ren China

Bojian Xie China

Fanming Kong China

Takanobu Irie Japan

Chen‐Sung Lin Taiwan

Mounes Aliyari Ghasebeh United States

Hye In Lim

144 ×1.3

191 ×1.9

72 ×0.9

ONCOL

50 ×0.7

SURGE

48 ×0.7

RNMI

Citations per year, relative to Hye In Lim Hye In Lim (= 1×) peers Mounes Aliyari Ghasebeh

Countries citing papers authored by Hye In Lim

Since Specialization

Citations

This map shows the geographic impact of Hye In Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hye In Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hye In Lim more than expected).

Fields of papers citing papers by Hye In Lim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hye In Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hye In Lim. The network helps show where Hye In Lim may publish in the future.

Co-authorship network of co-authors of Hye In Lim

This figure shows the co-authorship network connecting the top 25 collaborators of Hye In Lim. A scholar is included among the top collaborators of Hye In Lim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hye In Lim. Hye In Lim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Lim, Hye In, Yu Sun, Qinghong Han, Jun Yamamoto, & Robert M. Hoffman. (2021). Efficacy of Oral Recombinant Methioninase and Eribulin on a PDOX Model of Triple-negative Breast Cancer (TNBC) Liver Metastasis. In Vivo. 35(5). 2531–2534. 23 indexed citations

Sun, Yu, Hiroto Nishino, Norihiko Sugisawa, et al.. (2020). Oral Recombinant Methioninase Sensitizes a Bladder Cancer Orthotopic Xenograft Mouse Model to Low-dose Cisplatinum and Prevents Metastasis. Anticancer Research. 40(11). 6083–6091. 7 indexed citations

Lim, Hye In, Jun Yamamoto, Yu Sun, et al.. (2020). Response of Triple-negative Breast Cancer Liver Metastasis to Oral Recombinant Methioninase in a Patient-derived Orthotopic Xenograft (PDOX) Model. In Vivo. 34(6). 3163–3169. 19 indexed citations

Lim, Hye In, Jun Yamamoto, Sachiko Inubushi, et al.. (2020). A Single Low Dose of Eribulin Regressed a Highly Aggressive Triple-negative Breast Cancer in a Patient-derived Orthotopic Xenograft Model. Anticancer Research. 40(5). 2481–2485. 5 indexed citations

Lim, Hye In, Kazuyuki Hamada, Jun Yamamoto, et al.. (2020). Oral Methioninase Inhibits Recurrence in a PDOX Mouse Model of Aggressive Triple-negative Breast Cancer. In Vivo. 34(5). 2281–2286. 18 indexed citations

Kim, Hyuk Jung, et al.. (2016). Appendectomy: Should it be Performed So Quickly?. The American Surgeon. 82(1). 65–74. 27 indexed citations

Kim, Ki Ho, et al.. (2013). Comparative Analysis of Laparoscopic Versus Open Appendectomy for Perforated Appendicitis in Children Under 12 Years Old at a Single Institute. Daehan nae'si'gyeong bog'gang'gyeong oe'gwa haghoeji/Journal of minimally invasive surgery. 16(3). 69–73. 3 indexed citations

Kim, Ki Ho, et al.. (2012). Comparative Analysis Between Totally Extraperitoneal Repair and Prolene Hernia System at a Single Institute. Daehan nae'si'gyeong bog'gang'gyeong oe'gwa haghoeji/Journal of minimally invasive surgery. 15(3). 75–78. 1 indexed citations

Kim, Se Young, Ki Ho Kim, Byung Sun Suh, et al.. (2011). The Variation of Hepatic Duct Confluence and Asymptomatic Common Bile Duct Stone with Routine Intraoperative Cholangiogram during Laparoscopic Cholecystectomy. Korean Journal of Gastroenterology. 58(6). 338–338. 3 indexed citations

10.

Choe, Jun‐Ho, Wan Wook Kim, Hye In Lim, et al.. (2010). Comparison of calcitriol versus cholecalciferol therapy in addition to oral calcium after total thyroidectomy with central neck lymph node dissection: A prospective randomized study. Head & Neck. 33(9). 1265–1271. 15 indexed citations

11.

Kim, Sangmin, Jae Hyuck Choi, Hye In Lim, et al.. (2009). Silibinin prevents TPA-induced MMP-9 expression and VEGF secretion by inactivation of the Raf/MEK/ERK pathway in MCF-7 human breast cancer cells. Phytomedicine. 16(6-7). 573–580. 80 indexed citations

12.

Lim, Hye In, Jae Hyuck Choi, Jung‐Hyun Yang, et al.. (2009). Does pre-operative breast magnetic resonance imaging in addition to mammography and breast ultrasonography change the operative management of breast carcinoma?. Breast Cancer Research and Treatment. 119(1). 163–167. 37 indexed citations

13.

Choi, Jae Hyuck, Hye In Lim, Se Kyung Lee, et al.. (2009). The role of PET CT to evaluate the response to neoadjuvant chemotherapy in advanced breast cancer: Comparison with ultrasonography and magnetic resonance imaging. Journal of Surgical Oncology. 102(5). 392–397. 40 indexed citations

14.

Kim, Sangmin, Jae Hyuck Choi, Hye In Lim, et al.. (2009). EGF-induced MMP-9 expression is mediated by the JAK3/ERK pathway, but not by the JAK3/STAT-3 pathway in a SKBR3 breast cancer cell line. Cellular Signalling. 21(6). 892–898. 74 indexed citations

15.

Lee, Se Kyung, Jae Hyuck Choi, Hye In Lim, et al.. (2009). Experience with Intracystic Papillary Carcinoma of the Breast at a Single Institute in Korea. Journal of Breast Cancer. 12(4). 338–338. 2 indexed citations

16.

Lee, Se Kyung, Jae Hyuck Choi, Hye In Lim, et al.. (2009). Arm Sentinel Lymph Node Detection for Preserving the Arm Lymphatic System. Journal of Breast Cancer. 12(4). 272–272. 2 indexed citations

17.

Kim, Young-Wook, et al.. (2007). Successful Surgical Treatment of Aortoenteric Fistula. Journal of Korean Medical Science. 22(5). 846–846. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact